Vertebrate skeletogenesis involves two processes, skeletal patterning and osteoblast differentiation. Here, we show that Satb2, encoding a nuclear matrix protein, is expressed in branchial arches and in cells of the osteoblast lineage. Satb2 À/À mice exhibit both craniofacial abnormalities that resemble those observed in humans carrying a translocation in SATB2 and defects in osteoblast differentiation and function. Multiple osteoblast-specific genes were identified as targets positively regulated by SATB2. In addition, SATB2 was found to repress the expression of several Hox genes including Hoxa2, an inhibitor of bone formation and regulator of branchial arch patterning. Molecular analysis revealed that SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation. This synergy was genetically confirmed by bone formation defects in Satb2/Runx2 and Satb2/Atf4 double heterozygous mice. Thus, SATB2 acts as a molecular node in a transcriptional network regulating skeletal development and osteoblast differentiation.
INTRODUCTION
Skeletal development is initiated when mesenchymal cells aggregate at the location of and condense in the shape of future skeletal elements. These events, referred to as skeletal patterning, occur at various times throughout development of the skeleton and are controlled by major developmental signaling pathways and regulators of positional identity (Mariani and Martin, 2003) . During craniofacial development, neural crest cells migrate ventrolaterally from specific segmented regions of the hindbrain, termed rhombomeres, into the branchial arches to form specific components of the jaw apparatus (Hunt and Krumlauf, 1991; Bronner-Fraser, 1993; Kö ntges and Lumsden, 1996; Graham and Smith, 2001; Depew et al., 2002) . Key players in these patterning events are, among others, Hox proteins, which confer anterioposterior positional identity, and Dlx5 and -6, which regulate dorsoventral patterning (Trainor and Krumlauf, 2001; Depew et al., 2002; Santagati and Rijli, 2003) . Targeted inactivation of rhombomere-specific Hox genes and grafting experiments of neural crest cells indicate that patterning involves both segment-restricted Hox gene expression and interactions of migrating neural crest cells with the respective branchial arch environment (Chiaska et al., 1992; GendronMaguire et al., 1993; Rijli et al., 1993; Veitch et al., 1999) .
The second important event during skeletal development is the differentiation of cells of various origins into three specialized cell types: mesenchymal cartilage-forming chondrocytes and bone-forming osteoblasts as well as myelomonocytic bone-degrading osteoclasts. Few skeletal elements, including parts of the skull, are generated by direct differentiation of mesenchymal progenitor cells into bone-forming osteoblasts in a process termed intramembraneous ossification; most bones are formed by endochondral ossification via a cartilagenous template (Olsen, et al., 2000; de Crombrugghe et al., 2001) . Differentiation along the osteoblast lineage has been shown to depend on three transcriptional regulators. Runx2 and Osterix are both required for the early and late stages of osteoblast differentiation, whereby Runx2 is a master regulator that acts upstream of Osterix (Nakashima et al., 2002) . In addition, Atf4 regulates the terminal differentiation and function of osteoblasts, including the synthesis of the most abundant bone extracellular matrix protein, Type I collagen .
The function of various transcription factors and cis-acting sequences can be regulated by proteins that are part of the nuclear matrix and bind AT-rich sequences, referred to as nuclear matrix-attachment regions (MARs; Bode et al., 2000) . MAR sequences and MAR binding proteins have been implicated in the higher-order organization of chromatin and in the regulation of long-range interactions between enhancers and promoters (Cockerill and Garrard, 1986; Gasser and Laemmli, 1986; Jenuwein et al., 1997) . Several transcription factors, including Runx2, have been shown to associate with the nuclear matrix, and these associations have been implicated in the subnuclear localization and function of these transcription factors (Zaidi et al., 2005) .
SATB2 is a recently cloned member of the family of special AT-rich binding proteins that binds to MARs and activates transcription in a MAR-dependent manner (Dobreva et al., 2003; Britanova et al., 2005) . In humans, translocations that involve the chromosomal region 2q32-q33 and are associated with a cleft palate under conditions of haploinsufficiency have been found to interrupt the SATB2 gene (FitzPatrick et al., 2003) . SATB2 is closely related to the thymocyte-specific SATB1 protein (Kohwi-Shigematsu et al., 1997) . SATB1 regulates multiple genes and has been found to act as a repressor of transcription by recruiting the Sin3a histone deacetylase and subunits of the ACF nucleosome-mobilizing complex to target genes (Alvarez et al., 2000; Yasui et al., 2002) . In addition, SATB1 has been proposed to act by tethering MAR sequences onto its ''cage-like'' proteinaceous scaffold (Cai et al., 2003) .
Here, we analyze the function of SATB2 in skeletogenesis. We find that SATB2 represses the expression of Hoxa2 and activates several osteoblast-specific genes by augmenting the activity of both Runx2 and ATF4, suggesting that SATB2 acts as a molecular node in a transcriptional network regulating skeletogenesis.
RESULTS

Generation of Satb2 Knockout Mice and Analysis of Satb2 Expression in Development
To gain insight into the physiological role of SATB2, we inactivated the Satb2 gene in mouse embryonic stem (ES) cells by homologous recombination and in-frame insertion of the bacterial b-galactosidase (LacZ) gene immediately downstream of the first ATG codon in exon 2 ( Figure S1A ). Mice carrying a mutant Satb2-LacZ allele were mated to generate heterozygous and homozygous mutant mice ( Figure S1B ; data not shown). Immunoblot analysis of fetal brain tissue using anti-SATB2 and anti-b-Gal antibodies indicated that b-galactosidase protein, but not SATB2 protein, is detected in Satb2 À/À mice ( Figure S1C ). Thus, the targeted gene inactivation generated a null mutation of the Satb2 gene. We examined the developmental expression pattern of Satb2 by analyzing the presence of b-galactosidase activity in heterozygous Satb2 +/À mice between E8.5 and E14.5 ( Figures 1A and 1B) . Whole-mount staining for b-galactosidase activity revealed expression in the rhombomere region of the hindbrain at E8.5 and in the first branchial arch at E9. In addition, b-galactosidase activity was found in the hindgut diverticulum of E9 embryos. At E10.5, LacZ expression was detected in all four branchial arches, in the apical ectodermal ridge (AER), and in the zone of polarizing activity of the limb buds. Coronal sections indicated that LacZ expression is restricted to the medial portion of the branchial arches ( Figure 1A ). At E12.5 and E14.5, we detected abundant LacZ expression in the cortex of the brain and at sites of bone formation ( Figure 1B ). Additional LacZ expression was found in the spinal cord, kidneys, and the umbilical cord. We also confirmed by in situ hybridization that the pattern of LacZ expression in E15.5 and E16.5 Satb2 +/À embryos is virtually identical to that of endogenous Satb2 transcription in corresponding wild-type embryos ( Figures 1C and 1D ).
Perinatal Lethality, Cleft Palate, and Skeletal Patterning Defects in Satb2 À/À Mice Heterozygous Satb2 +/À mice are phenotypically normal and fertile. Homozygous mutant mice can be obtained with the expected Mendelian frequency; however, they die immediately after birth. Until E12.5, Satb2 À/À mice show no obvious morphological abnormalities, but starting at E14.5, the mutants can be easily recognized by a shorter lower jaw ( Figure S1D ). Alcian Blue/Alizarin Red staining of skeletal preparations of E17.5 embryos confirmed that the homozygous mutants have a shortened mandible and alterations of several intramembraneous bones that are derived from the first branchial arch (premaxilla, maxilla, nasal bones, frontal bones, and temporal processes of the squamous bone; Figures 1E and 1F ). Moreover, various skeletal elements that are derived from the second and third branchial arches, including the lesser horns and the body of the hyoid bone, are malformed ( Figure 1F ). In particular, the lesser horns are fused and show no articulation. The thyroid cartilage is missing from the laringeal cartilages, whereas the aryenoid, cricoid cartilages and the tracheal rings, derivatives of more caudal branchial arches, are normal ( Figure 1F ). The skeletal elements of the middle ear are also normal in the mutant mice (data not shown). SATB2 is expressed in the mandibular component of the first branchial arch, which gives rise to the lower jaw (Kö ntges and Lumsden, 1996; Fitzpatrick et al., 2003) . Histological analysis of the mandible of E18.5 heads in horizontal sections indicated that the posterior half of the homozygous mutant mandible appeared normally shaped and contained Meckel's cartilage and developing molar teeth (Figure 2A ). In contrast, the anterior part of the mandible, which contains normally the lower incisors and the anterior fusion of the Meckel's cartilage, is missing in the mutant mandible ( Figure 2A ). The incisor teeth, which express high levels of SATB2 in wild-type embryos, are missing in E17.5 Satb2 À/À embryos, although developing tooth germs can be detected at E13.5 ( Figures 2B, S1E , S1F, S1H, and S1I). The molars, which do not express SATB2, are unaffected in homozygous mutant embryos (Figures S1G, S1J, and S1K). Based on the association of a mutation in the human SATB2 locus with a cleft palate (FitzPatrick et al., 2003) , we examined coronal sections of heads of E17.5 embryos.
Satb2
À/À embryos show a cleft palate and a significantly smaller and shorter tongue, relative to wild-type embryos ( Figures 2B, S1H , and S1J). Scanning electron microscopy of the oral cavity roof at E14.5 suggested that the cleft palate defect in the Satb2 À/À embryos may be the result of a failure in the midline fusion of the palatal shelves and the drop-down of the tongue ( Figure 2C ). TUNEL assays to assess apoptosis and immunohistochemistry to detect both SATB2-LacZ expression, and BrdU incorporation indicated that cell proliferation and survival are normal in the b-Gal-positive mesenchyme of the mutant palatal shelves ( Figures 2D and S2A) . However, the Satb2 À/À palatal shelve mesenchyme generates bulges not observed in wild-type mice ( Figure 2C ), suggesting that the cleft palate may be caused by a patterning defect. We also examined whether phenotypic changes can be detected at earlier stages of development and observed enhanced apoptosis in the first branchial arch of E10.5 SATB2-deficient embryos ( Figure 2E ).
To gain insight into potential mechanisms underlying the craniofacial defects, we examined the expression of candidate genes that have been implicated in the patterning of branchial arch-derived structures. We performed quantitative RT-PCR with RNA isolated from cells in the head and branchial arch regions of E10.5 Satb2 +/À and Satb2 À/À embryos that have been loaded with the fluorogenic b-galactosidase substrate FDG and sorted by flow cytometry. As a control, we used cells that were negative for SATB2-LacZ expression. We failed to detect changes in the expression of Dlx5, Dlx6, Ptx1, Prx1, Prx2, dHand, and EphA7 ( Figure 2F ). However, we detected a 5-fold decrease in the level of Lhx7 expression and 4-to 6-fold increases in the expression of several Hox genes. In situ hybridizations to detect transcripts of Dlx1, Dlx2, Gsc, Ptx1, Alx3, and Msx2 did not reveal any obvious differences between wild-type and Satb2 À/À embryos; however, the expression domain of Msx1 is reproducibly extended in the mandible of E11.5 mutant embryos (Figures 2G and S2C-S2F; data not shown). Moreover, the expression of Lhx7 was decreased, consistent with the quantitative RT-PCR analysis ( Figure 2G ). The expression of Hoxa2 in the branchial arches was found to be relatively normal, although an upregulation was detected in the fronto-nasal processes ( Figure 2G ).
Defects of Osteoblast Differentiation in Satb2
À/À Mice
In addition to the craniofacial patterning defects, skeletal preparations of E15.5 Satb2 À/À embryos showed delayed bone formation or mineralization, as assessed by Alizarin Red-staining ( Figure S3A ). Staining of developing long bones with a van Gieson dye that labels collagen fibers showed that collagen levels are markedly reduced in E14.5 mutant compared to wild-type embryos, a difference even more pronounced in E15.5 embryos (Figures 3A and 3B) . Electron microscopy analysis showed a virtual absence of osteoid seams in the trabeculae of Satb2 À/À developing bones, suggesting a defect in extracellular matrix deposition ( Figure S3H ). X-gal staining of long bones of Satb2 +/À mice at E17.5 showed that SATB2 is expressed in the osteoblast lineage but not in chondrocytes ( Figure 3C ). Moreover, immunostaining of wildtype bones for SATB2 and costaining to detect tartrateresistant alkaline phosphatase-expressing osteoclasts indicated that SATB2 is not expressed in osteoclasts ( Figure S3E ). Analysis of molecular markers for osteoblast differentiation indicated that expression of Osterix (Osx) and alkaline phosphatase (AP) is reduced in long bones of E14.5 Satb2 À/À embryos ( Figure 3A ). Von Kossa staining to detect mineral deposits showed that the trabeculae of the homozygous mutant bone are shorter and thinner than those of the wild-type bone, whereas the growth plate is normal ( Figures 3D and S3F ). Von Kossa staining and quantitative micro-CT of vertebrae confirmed the marked defect in the formation of trabeculae and bone volume (Figures 3E and 3F) . We also examined the expression of bone sialoprotein (Bsp), an early marker for osteoblast differentiation, and osteocalcin (Ocn), a marker for terminal osteoblast differentiation, by in situ hybridization. Both markers were downregulated in long bones and calvariae of Satb2 À/À embryos (Figures 3D and S3D; data not shown). Quantification of the changes in the expression of these and other genes by real-time RT-PCR with RNA from calvarial osteoblasts indicated that Ocn and Bsp expression is reduced in the mutant cells 43-fold and 5-fold, respectively ( Figure 3G ). No change of Osterix expression was detected, whereas the expression of Runx2, Atf4, Dlx3, and Dlx5 was only modestly decreased ( Figure 3G ). Finally, we analyzed in cell culture the ability of Satb2
osteoblasts to differentiate into cells able to produce and mineralize an extracellular matrix. The percentage of bone nodules in Satb2 À/À osteoblasts was reduced 5-fold relative to wild-type and heterozygous osteoblasts, whereas cell proliferation was not altered ( Figure S4A ; data not shown). This defect was not rescued by the addition of bone morphogenetic protein-2 (BMP2), which induces the expression of both Runx2 and Satb2 in wild-type osteoblasts ( Figures S4A and S4B ).
SATB2 Regulates Multiple Genes in Osteoblasts and Represses Hoxa2 Expression
To gain insight into the role of SATB2 in osteoblasts, we performed gene expression profiling by hybridizing RNA from Satb2 +/À and Satb2 À/À calvarial osteoblasts that had been sorted for LacZ expression. The microarray analysis was performed on pools of five to six mice and showed that the expression of multiple genes, encoding transcription factors, extracellular matrix proteins, and growth factors are consistently deregulated in SATB2-deficient osteoblasts ( Figure 4A ). Consistent with the quantitative RT-PCR analysis of osteoblast cultures, expression of Bsp was markedly downregulated, whereas the expression of chondrocyte-specific extracellular matrix proteins (Collagen2a1, Collagen9a1, Matrilin, and Elastin) and chondrocyte-specific transcription factors (Sox5 and Sox6) were found to be upregulated. These changes in gene (G) In situ hybridization on transverse sections of E11.5 wild-type and Satb2 À/À embryos to detect Msx1 and Lhx7 transcripts (left-hand and middle). In situ hybridization to detect Hoxa2 transcripts in coronal sections of E10.5 embryos (right-hand) shows ectopic Hoxa2 expression in the frontonasal processes (arrowheads; the section level is indicated at the bottom). expression suggest that the SATB2-deficient osteoblasts have a more immature phenotype, consistent with their inability to fully differentiate when cultured in vitro (Figure S4A) . Notably, we also found a downregulation of Lhx7 expression and an upregulation of Hoxa2, which is also deregulated in the fronto-nasal region of Satb2
embryos. In addition to its role in craniofacial patterning, Hoxa2 has been shown to antagonize bone formation (Kanzler et al., 1998) . Consistent with these data, in situ hybridizations on coronal sections of E15.5 heads showed a marked upregulation of Hoxa2 expression in areas of SATB2-deficient calvarial bones that express SATB2-LacZ ( Figures  4B and S3C ). To confirm this result, we performed quantitative RT-PCR analysis on sorted LacZ-expressing primary osteoblasts and found that Satb2 À/À osteoblasts contained ten times more Hoxa2 transcripts than Satb2 +/À cells ( Figure 4C ). The level of Hoxa2 expression was reduced 4-fold in Satb2 À/À osteoblasts that have been transduced with a retrovirus expressing SATB2. The regulation of Hoxa2 gene expression has been analyzed in detail and shown to depend on a set of enhancers that control its expression in different tissues (Tumpel et al., 2002) . In particular, the intragenic EI enhancer and the downstream EII enhancer were found to determine Hoxa2 expression in rhombomeres 4 and 2, respectively ( Figure 4D ; Frasch et al., 1995) . In silico analysis of the Hoxa2 enhancer sequences by the MAR-Wiz algorithm identified a putative MAR element within the EII enhancer (Namciu et al., 2004 ; data not shown). To examine the binding of SATB2 to these regulatory elements in vivo, we infected primary osteoblasts with a retrovirus expressing FLAG-SATB2 and performed chromatin immunoprecipitation (ChIP) using an anti-FLAG antibody ( Figure 4E ). The immunoprecipitated chromatin fragments were analyzed with multiple primer pairs that allow for the amplification of different regions of the Hoxa2 enhancers. SATB2 was found to be bound to this region of the EII enhancer but not to the EI enhancer in vivo ( Figure 4E ). Moreover, binding to the EII enhancer appears to be direct, as recombinant SATB2 can efficiently bind to an oligonucleotide encompassing sequences of the EII enhancer in an electrophoretic mobility shift assay ( Figure S4C , lefthand). Finally, the expression of SATB2 was found to result in a 3-to 5-fold decrease in K4 methylation of histone H3 at the endogenous Hoxa2 gene ( Figure S4C , right-hand).
To assess the regulation of the EII enhancer by SATB2, we transfected an EII enhancer-luciferase gene construct into Satb2 +/À and Satb2 À/À osteoblasts. The activity of the EII enhancer was increased 4-fold in Satb2 À/À osteoblasts relative to Satb2 +/À cells, whereas the enhancer-less reporter gene was expressed at similar high levels (Figure 4F ). We also examined the effect of the deletion of the SATB2 binding region in the context of a transgene, in which a LacZ gene has been inserted into the Hoxa1 gene downstream of the EII enhancer (Frasch et al., 1995) . Deletion of the MAR resulted in some embryos in an ectopic expression in the cortex and AER of the limb buds, sites that normally express SATB2 ( Figures 1A  and S4D ). Figure 4G ). Taken together, these data indicate that the repression of Hoxa2 in calvarial osteoblasts by binding of SATB2 to the EII enhancer is important for normal osteoblast differentiation.
SATB2 Binds to and Regulates the Bone Sialoprotein and Osteocalcin Promoters
To assess the role of SATB2 in the regulation of Bsp and Ocn, we performed quantitative RT-PCR with RNA from primary osteoblasts that had been sorted for LacZ expression and cultured in vitro. In Satb2 À/À cells, we detected a 12-fold and 6-fold downregulation of Bsp and Ocn, respectively, whereas the expression of these genes was increased to normal levels in Satb2 À/À cells that had been transduced with a SATB2-expressing retrovirus (Figure 5A ). Previous studies of the bone sialoprotein (Bsp) promoter have identified three regulatory sequence elements in a region between À290 and À181 that determine osteoblast-specific promoter activity ( Figure 5B ; Benson et al., 2000) . ChIP analysis of wild-type osteoblasts that had been infected with a retrovirus expressing FLAG-tagged SATB2 showed binding of SATB2 to Bsp sequences that include the three osteoblast-specific sequence elements ( Figure 5B, lower panel) . No binding of SATB2 was detected with primers that amplify an upstream Bsp promoter region. In an EMSA we found that recombinant SATB2 efficiently bound to a Bsp oligonucleotide encompassing the wild-type site C but not to an oligonucleotide carrying mutations that have been previously shown to impair Bsp promoter activity ( Figure 5D , left-hand; Benson et al., 2000) .
The Ocn promoter has been extensively studied and shown to be regulated by Runx2 and ATF4, which bind the nonadjacent sequence elements OSE2 and OSE1, (E) Von Kossa staining in vertebrae sections of wild-type and Satb2 À/À embryos at E17.5 and E18.5. respectively ( Figure 5C ; Bidwell et al., 1993; Ducy and Karsenty, 1995; . To determine whether SATB2 is bound to the Ocn promoter in vivo, we performed
ChIP experiments with primary wild-type osteoblasts that had been infected with a FLAG-SATB2-expressing retrovirus or a GFP-expressing control virus. , and this defect is largely rescued (asterisks mark edges of the frontal and interparietal bones) in Satb2
Hoxa2
À/À embryos. Immunoprecipitation with anti-FLAG antibody and amplification with primers flanking the proximal OSE2 and OSE1 sequences indicated that SATB2 is bound to the endogenous Ocn promoter ( Figure 5C , lower panel). However, we failed to identify putative MAR elements using the MAR-Wiz algorithm and were unable to detect binding of SATB2 to either OSE2 or OSE1 in an EMSA ( Figure 5D , right-hand).
To obtain further evidence for a role of SATB2 in the regulation of Bsp and Ocn, we examined whether forced expression of SATB2 induces the expression of the endogenous genes. To this end, we infected C2C12 cells with a GFP-or SATB2-expressing retrovirus and analyzed Bsp and Ocn expression by quantitative RT-PCR. In SATB2-expressing cells, Bsp expression was increased 12-fold, whereas Ocn expression was not significantly altered ( Figure 5E ). Based on the noted similarity of the bone phenotype in Satb2 À/À and Atf4 À/À mice, we examined whether SATB2 could induce Ocn expression in combination with ATF4. We treated cells with the proteasome inhibitor MG115, which has been previously shown to stabilize ATF4 and Runx2 and increase Ocn expression (Yang and Karsenty, 2004) . As anticipated, MG115 treatment augmented Ocn expression $25-fold, and this activation was further enhanced by a factor of seven in SATB2-expressing cells ( Figure 5E ). Finally, we found that the forced expression of SATB2 in Satb2 À/À osteoblasts increased the acetylation of histone H3 and the RNA polymerase II occupancy of the Ocn promoter, relative to SATB2-deficient cells ( Figure 5F ).
Cooperation of SATB2 with Both ATF4 and Runx2
The augmentation of Ocn expression by SATB2 raised the question of whether SATB2 interacts functionally or physically with Runx2 and/or ATF4, the two key regulators of Ocn. To this end, we transfected transiently COS7 cells with an Ocn-luciferase reporter, alone or together, with various combinations of expression plasmids for SATB2, Runx2, and ATF4 ( Figures 6A and S5) . Individually, Runx2, but not SATB2 or ATF4, augmented the activity of the 647bp Ocn promoter fragment. However, SATB2 augmented the Runx2-mediated activation by a factor of three, and this stimulation was further enhanced by the co-expression of ATF4 ( Figure 6A ). To examine whether SATB2 directly stimulates the activation by ATF4 or Runx2, we used reporter plasmids that contain multimerized ATF4 binding sites (6xOSE1-luciferase; Figure 6B ) or multimerized Runx2 binding sites (6xOSE2-luciferase; Figure 6C ). SATB2 alone did not activate these reporters, but it augmented ATF4-and Runx2-mediated activation by factors of two and four, respectively (Figures 6B and 6C, black bars). As a control, SATB2 had no effect on reporters in which the ATF4-or Runx2 binding sites had been mutated ( Figures 6B and 6C, white bars) .
To delineate the domains of Runx2 and ATF4 that mediate the functional collaboration with SATB2, we transfected various deletion constructs of Runx2 and ATF4 together with a SATB2 expression plasmid. Deletion of the 108 amino-terminal residues of Runx2 abrogated the collaboration with SATB2, whereas the other deletions impaired activation of the 6xOSE2 reporter but did not affect stimulation by SATB2 ( Figure 6D ). Likewise, deletion of the 199 amino-terminal residues of ATF4 impaired the collaboration with SATB2 ( Figure 6E) .
Finally, we determined the effects of SATB2 on DNA binding by ATF4 and Runx2. We performed an EMSA with nuclear extracts from Ros cells, which contain endogenous Runx2 and ATF4 and have been infected with a SATB2-or GFP-expressing retrovirus ( Figure 6F ). Binding of ATF4 to OSE1 and Runx2 to OSE2 was detected, and the identities of the protein:DNA complexes were confirmed by the addition of anti-ATF4 or anti-Runx2 antibodies. No effect was observed by the addition of an anti-fos antibody. In extracts containing SATB2, an enhancement of DNA binding by both ATF4 and Runx2 was detected but without the appearance of slowermigrating protein:DNA complexes ( Figure 6F ).
Physical and Genetic Interaction of SATB2 with ATF4 and Runx2
To gain further insight into the collaboration of SATB2 with ATF4 and Runx2, we performed coimmunoprecipitations with extracts from 293 cells that had been transiently transfected with FLAG epitope-tagged SATB2 and various deletion constructs of Runx2 and ATF4 (Figures 7A and 7B) . Immunoprecipitations with an anti-FLAG antibody and subsequent immunoblot analysis with an anti-Runx2 antibody directed against amino-terminal sequences indicated that Runx2 and various C-terminal deletions are efficiently coimmunoprecipitated with FLAG-SATB2 ( Figure 7A ). To examine the effects of the deletion of the amino-terminal sequences of Runx2, we used His-tagged Runx2 constructs and found that the same region that mediates the functional collaboration with SATB2 is also required for coimmunoprecipitation ( Figure 7A ). Likewise, we also detected efficient coimmunoprecipitation of Myc-tagged and endogenous ATF4 with anti-FLAG antibody ( Figure 7B ). In this experiment, we could detect coimmunoprecipitation of the amino-terminal 200 residues of ATF4 ( Figure 7B , lower panel) and failed to coimmunoprecipitate the C-terminal residues ( Figure 7B, upper panel) . To determine whether the interactions of SATB2 with ATF4 and Runx2 are based on direct physical association, we performed His-and GSTpulldown experiments with purified recombinant proteins ( Figure 7C ). These experiments indicated that immobilized SATB2 could efficiently interact with ATF4, and reciprocal associations of SATB2 were detected with both ATF4 and Runx2. Taken together, these data show that SATB2 can physically interact with both ATF4 and Runx2, resulting in enhanced DNA binding and transactivation by these transcription factors.
To confirm the functional importance of the interactions detailed above in vivo, we examined whether the Satb2, Runx2, and Atf4 genes interact genetically. We crossed Satb2 +/À and Atf4 +/À mice and analyzed bone development by van Gieson staining of E15.5 long bones.
Satb2
+/À and Atf4 +/À bones showed normal formation of trabeculae and collagen fibrils, whereas double heterozygous bones displayed a marked reduction of bone formation ( Figure 7D ). Van Gieson staining of E17.5 long bones of Satb2/Runx2 double heterozygous and single heterozygous embryos revealed a significant bone defect in the double heterozygotes, which was further corroborated by micro-CT analysis of vertebrae at birth (Figures 7E and  7F ). The bone volume/total volume was reduced from 15.51% in wild-type mice to 3.53% in Satb2 
Atf4
+/À mice. Finally, we examined whether the genetic interaction of SATB2 with Runx2 could have a role in early stages of osteoblast differentiation. Indeed, in situ hybridization of Satb2 and Runx2 single and double heterozygous E15.5 bones to detect transcripts of the early molecular markers of bone formation, Osx and AP, showed a significant decrease in compound heterozygous embryos. Thus, Satb2 interacts genetically with both Atf4 and Runx2 ( Figure 7E ).
DISCUSSION
Regulation of Craniofacial Patterning by SATB2
In the developing mouse, starting at E8.5, Satb2 is expressed in the rhombomere region, at E9.0 in the first branchial arch, and subsequently in the medial parts of all four branchial arches that give rise to various facial structures of the adult (Hunt and Krumlauf, 1991; Bronner-Fraser, 1993; Kö ntges and Lumsden, 1996) . Consistent with this expression pattern, Satb2 À/À embryos show multiple craniofacial defects that include a significant truncation of the mandible, a shortening of the nasal and maxillary bones, malformations of the hyoid bone, and a cleft palate. By analyzing the expression of several (F) SATB2 enhances the binding of ATF4 and Runx2 to their respective binding sites. EMSA of nuclear extracts (2 mg) from ROS17 osteosarcoma cells infected with either GFP-or SATB2-expressing retroviruses to detect binding of ATF4 and Runx2 to OSE1 (lanes 1-5) and OSE2 (lanes 6-10) oligonucleotides, respectively. Sp1 binding served as a control for the quality and quantity of the extracts (not shown). The identity of the protein:DNA complexes was confirmed by their reactivity with anti-ATF4 or anti-Runx2 antibodies. Anti-Fos antibody was used as a negative control. genes implicated in craniofacial development, we identified Lhx7 and several Hox genes as potential target genes for SATB2. Targeted inactivation of Lhx7, also termed Lhx8, results in a defect in the fusion of the palatal shelves but does not impair the development of other oral structures that are affected in Satb2 À/À embryos (Zhao et al., 1999) . Moreover, mice homozygous for a null mutation of the Msx1 gene, which has an altered pattern of expression in Satb2 À/À embryos, display a cleft palate (Satokata and Maas, 1994) . The function of SATB2 in regulating palatogenesis is probably conserved during evolution as humans carrying deletions and balanced translocations involving chromosome 2q32-q33, which includes the SATB2 locus, show a failed fusion of the secondary palate, which is also observed in Satb2 À/À mice (FitzPatrick et al., 2003) . Targeted inactivation of Hoxa2, which is expressed in the epithelium of rhombomere r2 and in the migrating neural crest of r4, results in the transformation of second archspecific skeletal elements into first arch-specific elements (Gendron-Maguire et al., 1993; Rijli et al., 1993) . The structures altered in Hoxa2 À/À embryos appear to be normal in Satb2 À/À mice and, therefore, we consider it likely that additional SATB2-regulated genes contribute to the craniofacial defects in Satb2 À/À embryos.
Regulation of Hoxa2 by SATB2 in the Osteoblast Lineage
Beside defects in branchial arch patterning, Hoxa2
mice show an upregulation of the cartilage-and bonespecifying genes Sox9 and Runx2 (Kanzler et al., 1998) . Consistent with a function of Hoxa2 in antagonizing bone formation, transgenic overexpression of Hoxa2 in dermal bone precursors of the craniofacial area inhibits the formation of dermal bones, and the loss of Hox gene expression in cultured trunk neural crest cells correlates with the adoption of a skeletogenic fate (Kanzler et al., 1998; Creuzet et al., 2002) . Interestingly, we detect an ectopic upregulation of Hoxa2 in the forming calvarial bones of Satb2 À/À embryos at E15.5, and we could confirm the upregulation of Hoxa2 and Hoxb2 by quantitative RT-PCR assays with RNA from sorted osteoblasts ( Figures  4B and 4C) . Moreover, the rescue of the calvarial bone formation defect in Satb2
Hoxa2
À/À mice suggests that the repression of Hoxa2 by SATB2 is important for normal osteoblast differentiation.
The regulation of Hoxa2 has been studied extensively and shown to involve distinct cis-acting elements that mediate expression in the hindbrain and in neural crest cells (Tumpel et al., 2002) . In particular, an enhancer in the 3 0 region of the Hoxa2 gene, which has been implicated in autoregulation, has been found to direct LacZ expression in r2 and rostral somites (Frasch et al., 1995; Lampe et al., 2004) . In vivo and in vitro, we detected binding of SATB2 to a sequence of the EII enhancer that has the hallmarks of a MAR. A similar sequence is also found at the 3 0 end of the Hoxb2 gene that is bound by SATB2 as determined in ChIP experiments (unpublished observation). Moreover, we show that the activity of the Hoxa2 EII enhancer can be repressed by SATB2 in transfected osteoblasts, and we find that deletion of the MAR region in the context of a Hoxa2 transgene can result in the ectopic expression in regions that are positive for SATB2 expression in wildtype embryos. Taken together, our data suggest that SATB2 plays a role in downregulating Hoxa2 expression in osteoblasts.
Regulation of Osteoblast Differentiation and Function by SATB2
During skeletogenesis, the function of SATB2 is not restricted to the patterning of the craniofacial region. Previous analysis of the osteocalcin promoter, a wellstudied model for osteoblast-specific gene expression, has indicated that Runx2 and ATF4 synergize via nonadjacent binding sites (Xiao et al., 2005) . As ATF4 and Runx2 do not interact directly, it has been proposed that an additional protein mediates the functional synergy between these transcription factors. Our findings that SATB2 interacts with both Runx2 and ATF4 and augments their synergistic activation suggest that SATB2 may act to couple these osteoblast-specific transcription factors. Although this interaction enhances the binding of ATF4 and Runx2 to the osteocalcin promoter in vitro, this effect is modest and cannot explain the marked functional synergy. Therefore, SATB2 may participate in recruitment of proteins to specific subnuclear sites. Runx2 has been originally identified as NMP2, an osteoblast-specific MAR binding protein that associates with the nuclear matrix via a C-terminal targeting sequence and acts as a scaffold that targets regulatory factors and gene sequences to specific subnuclear sites (Bidwell et al., 1993; Choi et al., 2001; Zaidi et al., 2005) . However, SATB2 interacts with the aminoterminal domain of Runx2, which is also required for the functional synergy of Runx2 with ATF4. Moreover, SATB2 does not appear to mediate subnuclear targeting of Runx2, as the punctate nuclear distribution of Runx2 is not altered in Satb2
À/À osteoblasts (data not shown).
Therefore, we favor the view that SATB2 may act to recruit ATF4 to Runx2 multiprotein complexes in osteoblasts.
In conclusion, SATB2 is an unusual molecular determinant of skeletal development. It can act not only as an activating or repressing DNA bound protein but also as a protein scaffold that enhances the activity of other DNA binding proteins (Figure 8 ). By its ability to regulate the expression or activity of multiple key determinants of skeletal development, SATB2 appears to represent a molecular node of a transcriptional network underlying this process.
EXPERIMENTAL PROCEDURES
Satb2 Gene Targeting A b-galactosidase/pGKneo-pA cassette was inserted in frame with the ATG codon of the SATB2 gene. Homologous recombination was identified by Southern blot analysis with 5 0 internal and 3 0 external probes. Embryos were genotyped by PCR on DNA obtained from the yolk sacs or tail biopsies. Primer sequences for amplifying the homology arms of the targeting construct and for genotyping are provided upon request.
Morphological Analysis and In Situ Hybridization
For skeletal preparation, embryos were fixed in 95% ethanol. Alcian Blue/Alizarin Red staining was performed according to standard protocols. For histological analysis, embryos were fixed with 4% paraformaldehyde, embedded in paraffin, sectioned in 7mm thick slices, and stained with hematoxylin/eosin, von Kossa, and van Gieson reagents according to standard protocols. The micro-CT analysis was performed using the mCT40 Scanner according the standard criteria (Valentin et al. 2003) . LacZ staining and in situ hybridizations were performed on 20 mm thick cryosections. For detailed information, see Supplemental Experimental Procedures.
Cell Culture, Transient Transfections, and Reporter Assays Primary osteoblasts were isolated from E18.5 embryos essentially as described (Ducy and Karsenty, 1995) . C2C12 and COS7 cells were grown in a-MEM supplemented with 10% fetal bovine serum. Transient transfections were performed using Lipofectamine (invitrogen) according to the manufacturer's instructions.
Protein Expression, Pull-Down Assays, EMSA, Immunoprecipitation, and Immunoblot Analysis Recombinant proteins were expressed and purified, and pull-down assays were performed as previously described (Dobreva et al., 2003; . EMSA, coimmunoprecipitation, and chromatin immunoprecipitations were performed as described (Dobreva et al., 2003) . For oligonucleotides and primers, see Supplemental Experimental Procedures. For immunoblot analysis, antibodies were used in the following dilutions: anti-His (Santa Cruz) 1:1000; anti-ATF4 (Santa Cruz) 1:500; anti-Runx2 1:2000; and anti-b galactosidase 1:5000.
RNA Isolation, RT-PCR, and Real-Time PCR RNA was isolated using the Trizol reagent. Real-time PCR was performed with SYBR GREEN PCR master mix (Applied Biosystems) using the ABI PRISM 7000 sequence detection system. The cycle numbers were normalized to b-actin. Primer pairs are described in Supplemental Experimental Procedures.
FDG Loading and FACS Sorting
For the sorting of SATB2-LacZ positive cells, osteoblasts were loaded with fluorescein digalactoside (Molecular Probes) using hypotonic shock according to the manufacturer's instructions. After FDG loading, the cells were kept on ice for 30 min before FACS sorting and sorted on a Vantage cell sorter using the CellQuest software.
Supplemental Data
Supplemental Data include five figures and Experimental Procedures and can be found with this article online at http://www.cell.com/cgi/ content/full/125/5/971/DC1/.
